Results 31 to 40 of about 5,603,984 (294)

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.

open access: yesNew England Journal of Medicine, 2021
BACKGROUND Finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, has favorable effects on cardiorenal outcomes in patients with predominantly stage 3 or 4 chronic kidney disease (CKD) with severely elevated albuminuria and type 2 ...
B. Pitt   +10 more
semanticscholar   +1 more source

The association between neighbourhood greenspace and type 2 diabetes in a large cross-sectional study [PDF]

open access: yes, 2014
Objective: To investigate the relationship between neighbourhood greenspace and type 2 diabetes. Design: Cross-sectional. Setting: 3 diabetes screening studies conducted in Leicestershire, UK in 2004–2011.
Astell-Burt   +38 more
core   +1 more source

A Survey of Autoantibodies to Self Antigens in Graves' Disease Patients with Thyroid-Associated Ophthalmopathy

open access: yesEuropean Journal of Inflammation, 2013
Thyroid Associated Ophthalmopathy (TAO) is a complex pathology to treat and a considerable threat for Graves' Disease (GD) patients. Thus, there is great interest to find tools able to predict the onset and prognosis of TAO.
R. Bei   +14 more
doaj   +1 more source

Type 2 diabetes in children [PDF]

open access: yesBMJ, 2001
Type 2 diabetes mellitus in children is an emotionally charged issue and an emerging public health problem. 1 2 Until recently most children with diabetes mellitus had type 1, one of the most common3 and increasingly prevalent4 chronic diseases in children.
Anne Fagot-Campagna   +2 more
openaire   +3 more sources

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

open access: yesDiabetes Care, 2018
The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the prior position statements, published in 2012 and 2015, on the management of type 2 diabetes in adults.
M. Davies   +9 more
semanticscholar   +1 more source

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.

open access: yesNew England Journal of Medicine, 2020
BACKGROUND Finerenone, a nonsteroidal, selective mineralocorticoid receptor antagonist, reduced albuminuria in short-term trials involving patients with chronic kidney disease (CKD) and type 2 diabetes.
G. Bakris   +10 more
semanticscholar   +1 more source

IL-6 and Type 2 Diabetes

open access: yesمجلة كلية الطب, 2010
Background: Interleukin -6 (IL-6) as the key mediator of the acute phase reaction is of interest .elevated protein concentrations of IL-6 in the blood have been shown in patients with type 2 diabetes. This study aimed to investigate the association of IL-
Maha F. Almelan
doaj   +1 more source

The effects of Tai Chi on peripheral somatosensation, balance, and fitness in Hispanic older adults with type 2 diabetes:a pilot and feasibility study [PDF]

open access: yes, 2015
Peripheral neuropathy and loss of somatosensation in older adults with type 2 diabetes can increase risk of falls and disability. In nondiabetic older adult population Tai Chi has been shown to enhance balance and fitness through improvements in ...
Cavegn, Elisabeth I., Riskowski, Jody
core   +4 more sources

Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends

open access: yesJournal of Epidemiology and Global Health, 2019
The rising burden of type 2 diabetes is a major concern in healthcare worldwide. This research aimed to analyze the global epidemiology of type 2 diabetes.
Moien A. B. Khan   +5 more
semanticscholar   +1 more source

Sex differences in type 2 diabetes

open access: yesDiabetologia, 2023
The prevalence of type 2 diabetes mellitus is increasing in both sexes, but men are usually diagnosed at a younger age and lower body fat mass than women. Worldwide, an estimated 17.7 million more men than women have diabetes mellitus.
A. Kautzky-Willer   +2 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy